Authors:
OGERSHOK PR
KELLER FG
FAVARA BE
RITCHEY AK
Citation: Pr. Ogershok et al., AN UNUSUAL HISTIOCYTIC DISORDER RESPONDING TO CYCLOSPORINE THERAPY - A CASE-REPORT, Journal of pediatric hematology/oncology, 20(4), 1998, pp. 338-341
Authors:
KELLER FG
DEFAZIO J
JENCKS F
STEINER M
ROGERS J
RITCHEY AK
Citation: Fg. Keller et al., THE USE OF HEPARINASE TO NEUTRALIZE RESIDUAL HEPARIN IN BLOOD-SAMPLESDRAWN THROUGH PEDIATRIC INDWELLING CENTRAL VENOUS CATHETERS, The Journal of pediatrics, 132(1), 1998, pp. 165-167
Authors:
WINTER SS
HOWARD TA
RITCHEY AK
KELLER FG
WARE RE
Citation: Ss. Winter et al., ELEVATED LEVELS OF TUMOR NECROSIS FACTOR-BETA, GAMMA-INTERFERON, AND IL-6 MESSENGER-RNA IN CASTLEMANS DISEASE, Medical and pediatric oncology, 26(1), 1996, pp. 48-53
Authors:
ORTEL TL
CHARLES LA
KELLER FG
MARCOM PK
OLDHAM HN
KANE WH
MACIK BG
Citation: Tl. Ortel et al., TOPICAL THROMBIN AND ACQUIRED COAGULATION-FACTOR INHIBITORS - CLINICAL SPECTRUM AND LABORATORY DIAGNOSIS, American journal of hematology, 45(2), 1994, pp. 128-135
Citation: Fg. Keller et J. Kurtzberg, DISSEMINATED HISTOPLASMOSIS - A CAUSE OF INFECTION-ASSOCIATED HEMOPHAGOCYTIC SYNDROME, The American journal of pediatric hematology/oncology, 16(4), 1994, pp. 368-371
Authors:
ORTEL TL
QUINNALLEN MA
KELLER FG
PETERSON JA
LAROCCA D
KANE WH
Citation: Tl. Ortel et al., LOCALIZATION OF FUNCTIONALLY IMPORTANT EPITOPES WITHIN THE 2ND C-TYPEDOMAIN OF COAGULATION-FACTOR V USING RECOMBINANT CHIMERAS, The Journal of biological chemistry, 269(22), 1994, pp. 15898-15905
Authors:
WINTER SS
HOWARD TA
RITCHEY AK
KELLER FG
WARE RE
Citation: Ss. Winter et al., ELEVATED LEVELS OF TUMOR NECROSIS FACTOR-BETA, GAMMA-INTERFERON, AND IL-6 MESSENGER-RNA IN CASTLEMANS DISEASE, Blood, 84(10), 1994, pp. 10000650-10000650
Citation: Tl. Ortel et al., A FACTOR-V FACTOR-VIII LIGHT-CHAIN CHIMERA THAT EXPRESSES FACTOR-V PROCOAGULANT ACTIVITY AND IS RESISTANT TO NEUTRALIZATION BY A FACTOR-V INHIBITOR, Thrombosis and haemostasis, 69(6), 1993, pp. 1046-1046
Citation: Fg. Keller et al., FUNCTIONAL-CHARACTERIZATION OF THROMBIN CLEAVAGE SITES IN HUMAN COAGULATION FACTOR-V USING SITE-DIRECTED-MUTAGENESIS, Blood, 82(10), 1993, pp. 10000338-10000338